US Patent Issued to Factor Bioscience on Sept. 15 for "Engineered gene-editing proteins" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,687, issued on Sept. 15, was assigned to Factor Bioscience Inc. (Cambridge, Mass.).

"Engineered gene-editing proteins" was invented by Matthew Angel (Cambridge, Mass.), Franklin Kostas (Cambridge, Mass.), Mitchell Kopacz (Cambridge, Mass.) and Christopher Rohde (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates in part to nucleic acids encoding gene editing proteins, including novel engineered variants."

The patent was filed on Oct. 11, 2022, under Application No. 18/045,829.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2...